AmarnaBio
PrivateLast Round
Grant
Mar 13, 2025
Total Funding Raised
$50,000
Company Overview
AmarnaBio is a biotechnology company that uses an AI-driven platform to decode RNA regulatory networks for biomarker and drug target discovery, with a focus on neurological and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmarnaBio Comparables
Compare AmarnaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eclipsebio | 86% | |
| Envisagenics | 82% | |
| ReviR Therapeutics | 82% | |
AmarnaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 13, 2025 |
AmarnaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
$50K grant from KickStart Venture Services.
AmarnaBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AmarnaBio's valuation, stock price, and market status.